Thursday, July 23, 2015

What I'm Reading: The New York Times

Pharmaceutical cost transparency bills have been introduced in at least six states in the last year, aiming to make drug makers justify their prices.

A sharp increase in reported cases of the disease among people who often cannot afford treatment has prompted officials to create programs to try to stop its spread.

No comments:

Post a Comment